Families across the U.S. are facing devastating Medicaid cuts to autism therapy, jeopardizing their children's progress. Aubreigh Osborne's story highlights the urgent need for accessible treatment.
As Sudan grapples with a deadly civil war, Radio Dabanga remains the last independent news source for millions. With funding cuts threatening its survival, the station's role as a lifeline for Sudanese families has never been more critical.
In a groundbreaking move, President Trump has forged agreements with major pharmaceutical companies to significantly lower drug prices for Americans, ensuring access to affordable medications for chronic conditions.
A growing divide among Republicans highlights concerns over Trump's immigration policies affecting Afghan allies. As visa programs face cuts, key senators warn of the dangers posed to those who aided U.S. troops.
In a shocking move, the Department of Veterans Affairs is planning to eliminate up to 35,000 healthcare positions, predominantly unfilled roles, raising concerns about the future of veteran care and support.
In a major legal setback for Trump, a federal judge dismissed criminal charges against James Comey and Letitia James, citing improper prosecutor appointment. Meanwhile, the military plans to cut ties with the Boy Scouts, and new developments arise in the AI industry.
In a surprising move, Trump’s Department of Government Efficiency, known as DOGE, has been disbanded just months before its mandate was set to end. Critics question its impact on government savings, as many key employees transition to new roles within the administration.
As the House prepares to vote on a bill to end the longest government shutdown in U.S. history, tensions rise over the failure to extend healthcare subsidies. Will bipartisan support seal the deal?
President Trump claims his tariffs could finance a $2000 dividend for Americans, but experts raise serious doubts about the feasibility and legality of this plan. Is it a smart move or just political rhetoric?
As Trump promises $2,000 payments funded by tariffs, experts express skepticism about the financial feasibility and legal backing of his pledge. With tariff revenues projected to fall short, can Americans expect real dividends?